Buprenorphine MAT1, Urine, Medication Assisted Treatment (MAT)

TEST: 701957
Test number copied
CPT: 80307
Print Share

Special Instructions

This profile is designed for Suboxone™/buprenorphine medication assisted treatment. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.

Expected Turnaround Time

4 - 7 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Specimen Requirements

Specimen

Urine (random)

Volume

10 mL

Minimum Volume

3 mL

Container

Plastic urine container or transfer tube without preservative

Storage Instructions

Submission/Transport (<3 days): Room temperature. For storage beyond three days, specimen should be refrigerated or frozen.

Stability Requirements

Temperature

Period

Room temperature

14 days

Refrigerated

14 days

Frozen

6 weeks

Causes for Rejection

Insufficient volume; no ID on container; urine from preservative tube

Test Details

Use

This test is used to detect the presence of prescribed and illicit drugs for monitoring treatment of substance use disorder, including medication assisted treatment (MAT).

Methodology

Presumptive testing by immunoassay for buprenorphine at a testing threshold of 5 ng/mL; buprenorphine, norbuprenorphine, naloxone presumptive positives confirmed by definitive chromatography mass spectrometry (LC/MS-MS).

Initial presumptive testing by immunoassay at the following thresholds: alcohol biomarkers (EtG, EtS),500 ng/mL; amphetamines, 300 ng/mL; barbiturates, 200 ng/mL; benzodiazepines, 50 ng/mL; cocaine metabolite, 150 ng/mL; phencyclidine, 25 ng/mL; cannabinoids (THC), 20 ng/mL; heroin metabolite (6-AM), 10 ng/mL; opiates, 100 ng/mL; oxycodones, 100 ng/mL; tapentadol, 200 ng/mL; fentanyl, 2.0 ng/mL; methadone, 100 ng/mL; methadone mtb, 100 ng/mL; propoxyphene, 300 ng/mL; tramadol, 200 ng/mL; carisoprodol, 100 ng/mL; gabapentin, 1.0 ug/mL.

Definitive confirmation testing is not performed; contact laboratory if additional definitive testing is desired.

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf